CJC-1295 vs Hexarelin
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
PubMed paper counts, ClinicalTrials.gov listings, and regulatory context—aggregated from public databases.
GH release
A long-acting GHRH analog that extends GH pulses—often stacked with ipamorelin.
CJC-1295 mimics growth hormone-releasing hormone. The DAC version binds albumin for a longer half-life. Intended effects: lean mass support, sleep quality, and recovery. Prescription analogs exist in different forms; gra…
GH release
A potent GHRP-class peptide studied for GH release and, in preclinical work, heart tissue—popular in secretagogue stacks.
Hexarelin stimulates GH via ghrelin receptors and was investigated for cardiac effects in animal models. It desensitizes faster than some GHRPs with daily use. Not approved for human performance or cosmetic use; WADA pro…
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context. CJC-1295 is categorized as GH release; Hexarelin as GH release. CJC-1295: A long-acting GHRH analog that extends GH pulses—often stacked with ipamorelin. Hexarelin: A potent GHRP-class peptide studied for GH release and, in preclinical work, heart tissue—popular in secretagogue stacks.
No. They are different molecules with distinct names on labels and in research databases. Always match the full INCI or drug name—not a nickname on the front of the package.
Neither page is medical or anti-doping advice. Research peptides discussed in fitness communities may be prohibited in tested sport or unavailable as OTC supplements. Verify WADA lists and talk to a clinician.